Article

Immunological changes and prevention of disease progression through elotuzumab therapy in refractory IgG4-related sclerosing mesenteritis

Rheumatology (United Kingdom)
DOI: 10.1093/rheumatology/keac302
5Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Comdühr, S., Dübbers, A., Tharun, L., Graßhoff, H., Stone, J., Pitann, S., … Lamprecht, P. (2022, November 1). Immunological changes and prevention of disease progression through elotuzumab therapy in refractory IgG4-related sclerosing mesenteritis. Rheumatology (United Kingdom). Oxford University Press. https://doi.org/10.1093/rheumatology/keac302

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free